Press Releases
Hogan Lovells advises Labcorp on US$575 million acquisition of Personal Genome Diagnostics
27 December 2021
Leigh L. Oliver
PartnerWashington, D.C.
Email [email protected]hoganlovells.com
Phone +1 202 637 3648
Fax +1 202 637 5910
Practice groupGlobal Regulatory
She is extraordinarily attentive to detail and to strategy, an excellent team leader and very responsive to client needs.
Chambers USA 2022
From strategic transactions to government investigations, Leigh Oliver helps companies step through their most difficult antitrust issues. She represents clients before both state and federal antitrust enforcers on matters such as domestic and multijurisdictional mergers, joint ventures, and competitor collaborations.
Leigh is known in the antitrust bar for working with clients in some of the most heavily scrutinized industries, including health care, life sciences, and aerospace and defense. Her tireless work ethic and ability to build relationships with witnesses and clients to gain in-depth understanding of competitive market dynamics creates the formula for a winning strategy. Leigh was named "Lawyer of the Year – Under 40" by Global Competition Review (GCR) in 2017 and a Mergers & Acquisitions (M&A) and Antitrust Trailblazer by the National Law Journal for her work in 2016.
She has played a critical role in successfully defending companies in FTC merger investigations and challenges, including: Einstein Health Network’s merger with Thomas Jefferson University, Advocate Health Care’s merger with NorthShore University HealthSystem, and LabCorp v. FTC, which was named the 2011 "Litigation of the Year" by GCR.
Awards and recognitions
2021
Antitrust (District of Columbia)
Chambers USA
2019-2021
Healthcare: Advice to Service Providers, Next Generation Partner
Legal 500 US
2017-2021
Competition: Future Leaders, Most Highly Regarded
Who's Who Legal
2021
Healthcare: Global Leader
Who's Who Legal
2019
40 in their 40s: Notable Women Competition Professionals in Americas
[email protected]
2017-2019
Antitrust: Merger Control
Legal 500 US
2017
Lawyer of the Year - Under 40
Global Competition Review (GCR)
2017
Competition
Who's Who Legal
2016
Merger & Acquisitions (M&A) and Antitrust Trailblazer
National Law Journal
2015
Rising Star: Corporate, U.S. Northeast, U.S. South
Euromoney Legal Media Group's Americas Women in Business Law Awards
2009
Outstanding Healthcare Antitrust Lawyer
Nightingale's Health Care News
Education and admissions
Education
J.D., The Catholic University of America, Columbus School of Law, magna cum laude, 2004
B.A., Haverford College, 2000
Memberships
Co-Chair, ABA Antitrust Section Committee Operations
Member, American Bar Association (ABA)
Member, American Health Lawyers Association (AHLA)
Bar admissions and qualifications
District of Columbia
Maryland
Representative experience
Represented Einstein Health Network in successful defense of its merger with Thomas Jefferson University from preliminary injunction challenge by the FTC.
Represented Aspirus, Inc. in its acquisition of Ascension facilities in central, northern Wisconsin.
Represented Penn State Health in its acquisition of Geisinger’s Holy Spirit Hospital.
Represented Atrium Health and Wake Forest Baptist Medical Center in their combination.
Represented UW Health and UnityPoint Health in their proposed combination of healthcare provider and insurer services in Wisconsin.
Represented Advocate HealthCare in litigating the defense of its 2016 proposed merger with NorthShore University HealthSystem.
Counsel to LabCorp in various transactions in the drug development and diagnostics areas, including successful defense of its challenged merger with Westcliff Medical Laboratories.
Represented Lahey Health and Winchester Hospital in a combination that was reviewed by the Massachusetts Health Policy Commission.
Antitrust counsel to PPG Industries, Inc. in various transactions, including the acquisition of Akzo Nobel's architectural coatings business.
Represented GenCorp-Aerojet in its acquisition of Pratt & Whitney Rocketdyne, a transaction that was opposed by the FTC.
Antitrust counsel to Orbital Sciences in its acquisition of ATK.
Latest thinking and events
News
FTC establishes broad policy to require prior approval provisions in all merger divestiture orders
27 October 2021
News
FTC’s preliminary injunction win in hospital merger shows importance of deal and planning documents
28 September 2021
Awards and Rankings
Hogan Lovells Antitrust and Competition Lawyers Recognized as 2022 Thought Leaders and Future Leaders
04 August 2021
News
What health systems should know about President Biden’s Executive Order Promoting Competition
19 July 2021
Hogan Lovells Publications
Health care trends in a post-pandemic economy Life Sciences & Health Care Alert
13 July 2021
